3Dunaif A,Thomas A.Current concepts in the polycystic ovary syndrome[J].Annu Rev Med,2001,52:401-19.
4Robert J Norman,Ruijin Wu and Marcin T Stankiewicz[J].Polycystic ovary syndrome MJA,2004,180(3):132-137.
5Ibanez L,Potau N,Ferrer A,et al.Anovulation in eumenorrheic,nonobese adolescent girls born small for gestational age:insulin sensitization induces ovulation,increases lean body mass,and reduces abdominal fat excess,dyslipidemia,and subclinical hyperandrogenism[J].J Clin Endocrinol Metab,2002,87:5702-5705.
6Enrico Carmina and Rogerio A.LoboPolycystic Ovary Syndrome(PCOS):Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women[J].The Journal of Clinical Endocrinology & Metabolism,1999,84(6):1897-1899.
7Pierpoint T,McKeigue PM,Isaacs AJ,et al.Mortality of women with polycystic ovary syndrome at long-term follow-up[J].J Clin Epidemiol,1998,51:581-586.
8Yildiz BO,Chang W,Azziz R.Polycystic ovary syndrome and ovulation induction[J].Minerva Ginecol,2003,55(5):425-39.
9Vicenzo De Leo,Antonio la Marca,Raoul Orvieto and Giuseppe Morgante Effect of Metformin on Insulin-Like Growth Factor(IGF)I and IGF-Binding Protein I in Polycystic Ovary Syndrome[J].The Journal of Clinical Endocrinology & Metabolism,2000,85(4):1598-1600.
10Barbieri RL.Metformin for the treatment of polycystic ovary syndrome[J].Obstet Gynecol,2003,101(4):785-93.
